FindTrial
Sign In

Detection of HBV associated B-cell non-Hodgkin lymphoma markers by plasma proteomic analysis

Detection of HBV associated B-cell non-Hodgkin lymphoma markers by plasma proteomic analysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071036
Enrollment
Unknown
Registered
2023-04-29
Start date
2023-04-28
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic viral hepatitis B with B-cell non-Hodgkin lymphoma

Interventions

HBsAg-positive B-NHL patients:None.
HBsAg-negative B-NHL patients:None.
chronic hepatitis B infection patients:None.
healthy people:None.

Sponsors

Affiliated Hospital of Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis is clear: (1) B-cell non-Hodgkin lymphoma: pathologically diagnosed and immunohistochemical display as B-cell NHL; (2) Hepatitis B infection: hepatitis B surface antigen > 1.00 COI (normal value16 years old.

Exclusion criteria

Exclusion criteria: 1. The diagnosis is not clear. 2. Combined HIV and/or HCV. 3. Age less than 16 years old. 4. Patients with anaplastic lymphoma who are not clear in non-Hodgkin lymphoma who are derived from B lymphocytes or T lymphocytes and patients with incomplete data.

Design outcomes

Primary

MeasureTime frame
plasma proteins;;—

Countries

China

Contacts

Public ContactXiaoying Qi

Affiliated Hospital of Guangdong Medical University

769017443@qq.com+86 13469955246

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026